News & Alerts
-
Jun- 2022 -15 June
Ivermectin Does Not Help With COVID-19 Recovery Time – New Study
Ivermectin is a prescription drug. It comes as an oral tablet, topical cream, and topical lotion. Ivermectin oral tablet is…
Read More » -
15 June
FDA Approves World’s 1st Treatment For Alopecia
The FDA approved the nation’s first drug-fighting severe hair loss with the approval of Eli Lilly and Incyte’s systemic, daily pill June…
Read More » -
6 June
FDA Withdraws UKONIQ (umbralisib) Approval Over Safety Concerns
The FDA withdrew approval for a cancer medication known as umbralisib, used to treat marginal zone lymphoma and follicular lymphoma, over safety…
Read More » -
6 June
Overprescribing Stimulants: DOJ Investigating Telehealth Startup
Telehealth startup Cerebral has been subpoenaed by federal prosecutors after allegations of overprescribing controlled substances, The Wall Street Journal reported on May…
Read More » -
6 June
FDA Explains New Rules On Drug Importation From Canada
The FDA released a compliance guide May 25 featuring 12 questions and answers to provide small entities with a better understanding of…
Read More » -
Apr- 2022 -2 April
Ukraine War: Why Russians Are Panic Buying Antidepressants
(Reuters) – Russians have rushed to stock up on anti-depressants, sleeping pills, and contraceptives among other products since the conflict…
Read More » -
Mar- 2022 -23 March
Home COVID Tests Can Cause Harm FDA Warns
According to the U.S. Food and Drug Administration (FDA), popular at-home tests kits for COVID -19 can cause harm if they’re…
Read More » -
Feb- 2022 -19 February
Elmiron Lawsuit and Settlement Amounts
What is Elmiron and what is it used for? Elmiron is a brand of pentosan polysulfate sodium a medicine used…
Read More » -
16 February
Why Patients are Turning Down Paxlovid and Molnupiravir
According to the Center for Infectious Disease Research and Policy, at-home COVID-19 antiviral pills aren’t turning out to be the highly…
Read More » -
14 February
5 Facts About The China-developed Cancer Drug Rejected By The FDA
According to The New York Times report, the FDA advisory panel has voted against the approval of a lung cancer…
Read More »